Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging

International Journal of Rheumatic Diseases

Volumn 19, Issue 11, 2016, Pages 1169-1174

  Kobayashi, Yasuyuki ^a   Kobayashi, Hitomi ^b,c   Giles, Jon T ^d   Hirano, Masaharu ^e   Nakajima, Yasuo ^a   Takei, Masami ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Itabashi Chuo Medical Center   (Japan)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

cardiac magnetic resonance imaging; rheumatoid arthritis; tocilizumab; ventricular regional function

Indexed keywords

TOCILIZUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIMPLIFIED DISEASE ACTIVITY INDEX; ARTHRITIS, RHEUMATOID; ASYMPTOMATIC DISEASE; CASE CONTROL STUDY; CINE MAGNETIC RESONANCE IMAGING; COMPLICATION; CONVALESCENCE; DIAGNOSTIC IMAGING; DRUG EFFECTS; ETIOLOGY; JAPAN; PATHOPHYSIOLOGY; PILOT STUDY; PREDICTIVE VALUE; PREVENTION AND CONTROL; PROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASYMPTOMATIC DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; TIME FACTORS; TOKYO; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84951839925     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12632     Document Type: Article

References (18)

1. Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30, 36–40.
2. Nicola PJ, Crowson CS, Maradit-Kremers H et al. (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54, 60–7.
3. Maradit-Kremers H, Crowson CS, Nicola PJ et al. (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52, 402–11.
4. Dibbs Z, Thornby J, White BG et al. (1999) Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol 33, 1935–42.
5. Dayer JM, Choy E (2010) Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology 49, 15–24.
6. Raymond RJ, Dehmer GJ, Theoharides TC et al. (2001) Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141, 435–8.
7. Wollert KC, Drexler H (2001) The role of interleukin-6 in the failing heart. Heart Fail Rev 6, 95–103.
8. Tsutamoto T, Hisanaga T, Wada A et al. (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31 (2), 391–8.
9. Fernandes VR, Edvardsen T, Rosen BD et al. (2007) The influence of left ventricular size and global function on regional myocardial contraction and relaxation in an adult population free of cardiovascular disease: a tagged CMR study of the MESA cohort. J Cardiovasc Magn Reson 9 (6), 921–30.
10. van der Linden MP, Knevel R, Huizinga TW et al. (2011) Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum 63, 37–42.
11. Schuster A, Kutty S, Padiyath A et al. (2011) Cardiovascular magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress. J Cardiovasc Magn Reson 13, 58.
12. Schuster A, Paul M, Bettencourt N et al. (2013) Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy. Int J Cardiol 166, 413–20.
13. Helle-Valle TM, Yu WC, Fernandes VR et al. (2010) Usefulness of radial strain mapping by multidetector computer tomography to quantify regional myocardial function in patients with healed myocardial infarction. Am J Cardiol 106, 483–91.
14. Mustonen J, Laakso M, Hirvonen T et al. (1993) Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest 23, 246–53.
15. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52, 412–20.
16. Cathcart ES, Spodick DH (1962) Rheumatoid heart disease. A study of the incidence and nature of cardiac lesions in rheumatoid arthritis. N Engl J Med 266, 959–64.
17. Birks EJ, Burton PBJ, Owen V et al. (2000) Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 102, 352–8.
18. Shapiro EP, Rogers WJ, Beyar R et al. (1989) Determination of left ventricular mass by magnetic resonance imaging in hearts deformed by acute infarction. Circulation 79 (3), 706–11.